Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.

Journal Article (Journal Article)

Two-component, self-assembling nanoparticles represent a versatile platform for multivalent presentation of viral antigens. Computational design of protein nanoparticles with differing sizes and geometries enables combination with antigens of choice to test novel multimerization concepts in immunization strategies where the goal is to improve the induction and maturation of neutralizing antibody lineages. Here, we describe detailed antigenic, structural, and functional characterization of computationally designed tetrahedral, octahedral, and icosahedral nanoparticle immunogens displaying trimeric HIV envelope glycoprotein (Env) ectodomains. Env trimers, based on subtype A (BG505) or consensus group M (ConM) sequences and engineered with SOSIP stabilizing mutations, were fused to an underlying trimeric building block of each nanoparticle. Initial screening yielded one icosahedral and two tetrahedral nanoparticle candidates, capable of presenting twenty or four copies of the Env trimer. A number of analyses, including detailed structural characterization by cryo-EM, demonstrated that the nanoparticle immunogens possessed the intended structural and antigenic properties. When the immunogenicity of ConM-SOSIP trimers presented on a two-component tetrahedral nanoparticle or as soluble proteins were compared in rabbits, the two immunogens elicited similar serum antibody binding titers against the trimer component. Neutralizing antibody titers were slightly elevated in the animals given the nanoparticle immunogen and were initially more focused to the trimer apex. Altogether, our findings indicate that tetrahedral nanoparticles can be successfully applied for presentation of HIV Env trimer immunogens; however, the optimal implementation to different immunization strategies remains to be determined.

Full Text

Duke Authors

Cited Authors

  • Antanasijevic, A; Ueda, G; Brouwer, PJM; Copps, J; Huang, D; Allen, JD; Cottrell, CA; Yasmeen, A; Sewall, LM; Bontjer, I; Ketas, TJ; Turner, HL; Berndsen, ZT; Montefiori, DC; Klasse, PJ; Crispin, M; Nemazee, D; Moore, JP; Sanders, RW; King, NP; Baker, D; Ward, AB

Published Date

  • August 2020

Published In

Volume / Issue

  • 16 / 8

Start / End Page

  • e1008665 -

PubMed ID

  • 32780770

Pubmed Central ID

  • PMC7418955

Electronic International Standard Serial Number (EISSN)

  • 1553-7374

Digital Object Identifier (DOI)

  • 10.1371/journal.ppat.1008665


  • eng

Conference Location

  • United States